About Instytut Zdrowia dr Boczarska-Jedynak
"We wrześniu 2018 r. powstaliśmy z myślą specjalnie o Tobie i Twoich bliskich! Instytut Zdrowia dr Boczarskiej-Jedynak to jedna z najnowocześniejszych, niepublicznych placówek medycznych w Małopolsce, ukierunkowana na personalizowaną opiekę medyczną."
Clinical Trials at Instytut Zdrowia dr Boczarska-Jedynak
During the past decade, Instytut Zdrowia dr Boczarska-Jedynak conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Instytut Zdrowia dr Boczarska-Jedynak" #1 sponsor was "H. Lundbeck A/S" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Theravance Biopharma" with 2 trials sponsored, "Averitas Pharma, Inc." with 1 trials sponsored and "Immunic AG"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
Clinical Trials Conditions at Instytut Zdrowia dr Boczarska-Jedynak
According to Clinical.Site data, the most researched conditions in "Instytut Zdrowia dr Boczarska-Jedynak" are
"Migraine" (2 trials), "Multiple Sclerosis" (2 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials), "Essential Tremor of the Upper Limb" (1 trials) and "MSA" (1 trials). Many other conditions were trialed in "Instytut Zdrowia dr Boczarska-Jedynak" in a lesser frequency.
Clinical Trials Intervention Types at Instytut Zdrowia dr Boczarska-Jedynak
Most popular intervention types in "Instytut Zdrowia dr Boczarska-Jedynak" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "ampreloxetine" (2 trials), "Antihistamine" (1 trials), "Eptinezumab" (1 trials) and "Fenebrutinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instytut Zdrowia dr Boczarska-Jedynak
The vast majority of trials in "Instytut Zdrowia dr Boczarska-Jedynak" are
11 trials for "All" genders.
Clinical Trials Status at Instytut Zdrowia dr Boczarska-Jedynak
Currently, there are NaN active trials in "Instytut Zdrowia dr Boczarska-Jedynak".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Instytut Zdrowia dr Boczarska-Jedynak,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instytut Zdrowia dr Boczarska-Jedynak, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".